Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 7051–7100 of 75417
On August 31, 2024, James A. Lico notified the Board of Directors of Fortive Corporation (the “Company” or “Fortive”) of his decision to retire as President and Chief Executive Officer, and as a director, of the Company, effective upon the consummation of the proposed spin-off
On September 4, 2024, Voya Financial, Inc. (the “Company”) announced that Don Templin, Executive Vice President and Chief Financial Officer, informed the Company of his decision to retire from the Company.
On September 1, 2024, Frank D. Lee notified the Company of his resignation as a member of the Board and the committees thereof, effective as of September 3, 2024.
On August 28, 2024, James Healy, M.D., Ph.D., notified Bolt Biotherapeutics, Inc. (the “Company”) of his resignation as a member of the Company’s Board of Directors (the “Board”) and the committees thereof, effective as of September 3, 2024.
Mr. Hulette's appointment will fill the vacancy created by the recent retirement of Tony D. Whitaker from the Board of Directors of the Company.
On August 28, 2024, Mr. Matthew Barger notified iLearningEngines, Inc. (the “Company”) of his intention to resign from the board of directors of the Company (the “Board”) and all committees thereof.
succeed the Company’s current President and Chief Executive Officer, Dr. Stephen Schwartz, who as previously announced is retiring effective as of the Start Date
Steve Anderson notified the Company of his decision to resign from the Company's Board, effective September 6, 2024.
On September 2, 2024, Tamar Yehoshua notified the board of directors (the “Board”) of the Company of her intention to resign as a member of the Board, effective at the end of the day on September 13, 2024.
Glynis Bryan, the Company’s Chief Financial Officer, intends to retire as Chief Financial Officer effective December 31, 2024.
On August 28, 2024, we certified the election by our member, Columbus Electric Cooperative, Inc., of Zane Shanon Nunn to replace Chris Martinez, as the director representing them on our Board of Directors.
Christine Rupp departed her position as Chief Customer Officer of the Company
Greg Unis departed his position as Brand President of the Company
each of Dale S. Rosenthal, Michael S. Della Rocca, Edward A. Ryan and David M. Sparby (collectively, the “Prospective Everus Construction Directors”) are expected to resign as directors of the Company
each of Dale S. Rosenthal, Michael S. Della Rocca, Edward A. Ryan and David M. Sparby (collectively, the “Prospective Everus Construction Directors”) are expected to resign as directors of the Company
each of Dale S. Rosenthal, Michael S. Della Rocca, Edward A. Ryan and David M. Sparby (collectively, the “Prospective Everus Construction Directors”) are expected to resign as directors of the Company
each of Dale S. Rosenthal, Michael S. Della Rocca, Edward A. Ryan and David M. Sparby (collectively, the “Prospective Everus Construction Directors”) are expected to resign as directors of the Company
On September 3, 2024, STRATTEC SECURITY CORPORATION (the “Company”) announced the departure from the Company of Al-Waleed H. Hamdan, Vice President – Global Sales and Product Management and Chief Commercial Officer, effective October 3, 2024.
he will continue to serve as SITE Centers’ Executive Vice President, Chief Financial Officer and Treasurer until the Spin-Off Date (at which time he is expected to cease serving in such roles for SITE Centers)
David Sangster, Chief Operating Officer of Nutanix, Inc. (the “Company”), notified the Company of his decision to retire as Chief Operating Officer, effective October 31, 2024.
Stephen LaMond, PharmD., MBA resigned from his positions as Interim Chief Executive Officer and Chief Operating Officer of Peak Bio, Inc. (the “Company”), effective August 31, 2024.
On August 30, 2024, Joseph Jaeger, President, Americas of First Advantage Corporation (“First Advantage”), notified First Advantage of his intention to retire from such position, effective November 1, 2024 (the “Retirement Date”).
On August 28, 2024, Michael J. Fox notified Cue Biopharma, Inc. (the “Company”) of his decision to resign as a member of the Board of Directors of the Company (the “Board”) and all committees thereof, effective on August 28, 2024.
On August 27, 2024, Kara Sprague, Executive Vice President and Chief Product Officer of F5, Inc., notified the Company that she will resign from her position effective November 2, 2024.
John Gandolfo retired from his positions as Chief Financial Officer, Treasurer and Secretary of Eyenovia, Inc. (the “Company”).
On August 27, 2024, Ali Behbahani gave notice of his intention to resign from the Board effective at the close of business on September 2, 2024.
Curtis McWilliams and Adam Markman have tendered their resignations from the board of directors
Curtis McWilliams and Adam Markman have tendered their resignations from the board of directors
Jonathan McNeill, M.D., the Company’s Chief Business Officer, and Susanna High, the Company’s Chief Operating Officer, each notified the Company of their intention to resign their employment.
Jonathan McNeill, M.D., the Company’s Chief Business Officer, and Susanna High, the Company’s Chief Operating Officer, each notified the Company of their intention to resign their employment.
As previously disclosed by the Company, Bruce Greenberg stepped down from his positions with the Company, including as the Company’s Senior Vice President of Finance, Interim Chief Financial Officer and principal financial officer and principal accounting officer as of the Effective Date.
On August 30, 2024, Mr. Kenneth Galbraith resigned from the positions of interim Chief Financial Officer and as principal financial officer and principal accounting officer of the Company, effective as of the Start Date.
On August 28, 2024, Suzanne Winter, President and Chief Executive Officer of Accuray Incorporated (the “Company”) informed the board of directors of the Company (the “Board”) that she is taking a temporary medical leave of absence, effective September 3, 2024.
On September 3, 2024, Baxter International Inc. (the “ Company ”) and Mr. Brian Stevens mutually agreed that he will resign from his role as the Company’s Senior Vice President, Chief Accounting Officer and Controller and principal accounting officer (“ PAO ”) and will no longer be an employee of the Company as of the same date.
In connection with the Termination Agreement, Mr. Gao resigned as the chief operating officer of the Company, effective September 30, 2024.
On August 27, 2024, Sonalee Parekh informed RingCentral, Inc. (the “Company”) of her intention to resign as the Company’s Chief Financial Officer and as the Company’s principal financial officer under Section 16a-1(f) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), effective September 10, 2024, to accept a Chief Financial Officer role at a public company that is not a competitor, supplier, or customer of RingCentral.
Tim Wan tendered to the Board of Directors (the “Board”) of Asana, Inc. (the “Company”) his resignation as Chief Financial Officer of the Company, effective as of September 10, 2024.
Mr. Jolley will continue as an employee of the Company, serving as senior adviser, finance, effective November 1, 2024.
On September 3, 2024, Trevor S. Lang, President of Floor & Decor Holdings, Inc. (the “Company”), informed the Company that he intends to retire from the Company.
On September 1, 2024, Jason O’Byrne, the Chief Financial Officer of Caribou Biosciences, Inc. (the “Company”), informed the Company of his intent to resign from his position, effective September 27, 2024, to pursue another opportunity.
On August 28, 2024, Malcolm Salter informed the Board of Directors (the “Board”) of C4 Therapeutics, Inc. (the “Company”) of his intention to resign from the Board, effective upon the appointment of his successor.
On August 30, 2024, the Company and Mr. Sievers mutually agreed that Mr. Sievers would separate from the Company as its Chief Operating Officer effective September 30, 2024.
On August 30, 2024, Ms. Themis Glatman resigned her position as an officer and Director of the Corporation.
On August 28, 2024, Mr. Bryan Capelli resigned his position as a Director of the Corporation.
Innovid Corp. (“Innovid” or the “Company”) announces that Dave Helmreich, Chief Commercial Officer of the Company, will be leaving the business by mutual consent to pursue other opportunities, effective from the close of business on August 30, 2024.
On August 28, 2024, Mariann Wojtkun Marshall, Vice President and Chief Accounting Officer of The Progressive Corporation (the “Company”), notified the Company of her decision to retire from these positions in mid-2025
Mr. Stein, previously the Chief Operating Officer of the segment, succeeds Daniel Halftermeyer, who is stepping down from the position to focus his time and energies on driving the continued integration of the Company’s Heimbach acquisition and ensuring a successful transition to Mr. Stein.
On August 27, 2024, Amerino Gatti notified the Board of Directors (the “Board”) of Helix Energy Solutions Group, Inc. (“Helix” or the “Company”) of his intention to resign as a director of the Company effective as of August 30, 2024.
Lauren S. Fisher, the Company’s Senior Vice President and Chief Legal Officer will cease serving in her role and will leave the Company, effective as of September 6, 2024.
On August 29, 2024, C. Timothy Trenary, 68, Executive Vice President, Chief Financial Officer of Superior Industries International, Inc. (the “Company” or “Superior”), notified the Company of his intent to retire from his position at Superior effective September 30, 2024.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.